216 related articles for article (PubMed ID: 23596528)
1. Murine cytomegalovirus immediate-early 1 gene expression correlates with increased GVHD after allogeneic hematopoietic cell transplantation in recipients reactivating from latent infection.
Palaniyandi S; Radhakrishnan SV; Karlsson FJ; Stokes KY; Kittan N; Huber E; Hildebrandt GC
PLoS One; 2013; 8(4):e61841. PubMed ID: 23596528
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy alleviates murine cytomegalovirus recurrence by reducing TNF-α post cell transplantation with lethal GVHD.
Deng J; Xiao J; Lv L; Ma P; Song X; Gao B; Gong F; Zhang Y; Xu J
Antiviral Res; 2016 Sep; 133():130-9. PubMed ID: 27465366
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
Roback JD; Hossain MS; Lezhava L; Gorechlad JW; Alexander SA; Jaye DL; Mittelstaedt S; Talib S; Hearst JE; Hillyer CD; Waller EK
J Immunol; 2003 Dec; 171(11):6023-31. PubMed ID: 14634114
[TBL] [Abstract][Full Text] [Related]
4. Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.
Hossain MS; Jaye DL; Pollack BP; Farris AB; Tselanyane ML; David E; Roback JD; Gewirtz AT; Waller EK
J Immunol; 2011 Nov; 187(10):5130-40. PubMed ID: 22013117
[TBL] [Abstract][Full Text] [Related]
5. Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.
Holtappels R; Schader SI; Oettel O; Podlech J; Seckert CK; Reddehase MJ; Lemmermann NAW
Front Cell Infect Microbiol; 2020; 10():157. PubMed ID: 32351904
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
7. The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs.
Busche A; Marquardt A; Bleich A; Ghazal P; Angulo A; Messerle M
J Virol; 2009 May; 83(9):4030-8. PubMed ID: 19211741
[TBL] [Abstract][Full Text] [Related]
8. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.
Simon CO; Holtappels R; Tervo HM; Böhm V; Däubner T; Oehrlein-Karpi SA; Kühnapfel B; Renzaho A; Strand D; Podlech J; Reddehase MJ; Grzimek NK
J Virol; 2006 Nov; 80(21):10436-56. PubMed ID: 16928768
[TBL] [Abstract][Full Text] [Related]
9. Stochastic Episodes of Latent Cytomegalovirus Transcription Drive CD8 T-Cell "Memory Inflation" and Avoid Immune Evasion.
Griessl M; Renzaho A; Freitag K; Seckert CK; Reddehase MJ; Lemmermann NAW
Front Immunol; 2021; 12():668885. PubMed ID: 33968074
[TBL] [Abstract][Full Text] [Related]
10. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury.
Wang H; Asavaroengchai W; Yeap BY; Wang MG; Wang S; Sykes M; Yang YG
Blood; 2009 Apr; 113(15):3612-9. PubMed ID: 19211507
[TBL] [Abstract][Full Text] [Related]
12. Increased morbidity and mortality in murine cytomegalovirus-infected mice following allogeneic bone marrow transplant is associated with reduced surface decay accelerating factor expression.
El-Amouri IS; Bani-Ahmad M; Tang-Feldman Y; Lin F; Ko C; Pomeroy C; Oakley OR
Clin Exp Immunol; 2010 Nov; 162(2):379-91. PubMed ID: 20840652
[TBL] [Abstract][Full Text] [Related]
13. Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.
Liu XF; Jie C; Zhang Z; Yan S; Wang JJ; Wang X; Kurian S; Salomon DR; Abecassis M; Hummel M
J Gen Virol; 2016 Apr; 97(4):941-954. PubMed ID: 26795571
[TBL] [Abstract][Full Text] [Related]
14. TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
Kumari R; Palaniyandi S; Strattan E; Huang T; Kohler K; Jabbour N; Dalland J; Du J; Kesler MV; Chen YH; Hildebrandt GC
Transplantation; 2020 Mar; 104(3):500-510. PubMed ID: 31634333
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
[TBL] [Abstract][Full Text] [Related]
16. Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs.
Simon CO; Seckert CK; Dreis D; Reddehase MJ; Grzimek NK
J Virol; 2005 Jan; 79(1):326-40. PubMed ID: 15596827
[TBL] [Abstract][Full Text] [Related]
17. Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation.
Seckert CK; Renzaho A; Tervo HM; Krause C; Deegen P; Kühnapfel B; Reddehase MJ; Grzimek NK
J Virol; 2009 Sep; 83(17):8869-84. PubMed ID: 19535440
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
[TBL] [Abstract][Full Text] [Related]
20. A model for reactivation of CMV from latency.
Hummel M; Abecassis MM
J Clin Virol; 2002 Aug; 25 Suppl 2():S123-36. PubMed ID: 12361763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
